ID

25470

Beschreibung

Study ID: 101468/166 Clinical Study ID: SKF-101468/166 Study Title: A Phase II, randomised, double-blind, active-controlled, dose-escalation study to determine the maximum well-tolerated starting dose of a new formulation of ropinirole in Parkinson's Disease patients not receiving other dopaminergic therapies Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 2 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: requip Study Indication: Parkinson Disease

Stichworte

Versionen (2)
  1. 24.08.17 24.08.17 -
  2. 04.09.17 04.09.17 -
Hochgeladen am

4. September 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

end of study starting dose of ropinirole Parkinson's Disease 101468/166

Englisch

end of study starting dose of ropinirole Parkinson's Disease 101468/166

1 Formulare  
Administrative Data
Beschreibung

Administrative Data

Alias
UMLS CUI-1
C1320722
Patient Initials
Beschreibung

patient's initials

Datentyp

text

Alias
UMLS CUI [1]
C2986440
Patient No.
Beschreibung

patient number

Datentyp

integer

Alias
UMLS CUI [1]
C1830427
Date of Visit
Beschreibung

date of visit

Datentyp

date

Alias
UMLS CUI [1]
C1320303
COMPLETION OF TREATMENT PHASE
Beschreibung

COMPLETION OF TREATMENT PHASE

Alias
UMLS CUI-1
C0580352
Date of termination
Beschreibung

date of study termination

Datentyp

date

Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C0008972
UMLS CUI [1,3]
C0013135
Did the patient remain on study drug through Day 7?
Beschreibung

patient's study participation status

Datentyp

integer

Did the patient remain on study drug through Day 7?
Beschreibung

If "NO, discontinued study drug prematurely"; tick the one most significant reason below

Datentyp

integer

COMPLETION THROUGH DAY 14
Beschreibung

COMPLETION THROUGH DAY 14

Alias
UMLS CUI-1
C2348568
Did the patient complete study visits/prodcedures through Day 14?
Beschreibung

patient's study participation status

Datentyp

integer

Did the patient complete study visits/prodcedures through Day 14?
Beschreibung

If "NO, check the one most significant reason below", choose a reason below.

Datentyp

integer

Date of last contact
Beschreibung

If "Lost to follow-up" above, record the date.

Datentyp

date

Alias
UMLS CUI [1]
C0805839
PATIENT DEATH
Beschreibung

PATIENT DEATH

Alias
UMLS CUI-1
C1306577
Date of death
Beschreibung

date of death

Datentyp

date

Alias
UMLS CUI [1]
C1148348
Was an autopsy performed?
Beschreibung

If YES, attach a copy of the autopsy report.

Datentyp

integer

Alias
UMLS CUI [1]
C0004398
Primary cause of death
Beschreibung

primary cause of death

Datentyp

text

Alias
UMLS CUI [1]
C0007465
Underlying cause(s) of death
Beschreibung

underlying causes of death

Datentyp

text

Alias
UMLS CUI [1]
C0007465
Was death related to study drug?
Beschreibung

death related to study drug

Datentyp

integer

Alias
UMLS CUI [1,1]
C0011065
UMLS CUI [1,2]
C0304229
INVESTIGATOR'S SIGNATURE
Beschreibung

INVESTIGATOR'S SIGNATURE

Alias
UMLS CUI-1
C2346576
Signature
Beschreibung

I have assumed reponsibility for completeness and accuracy of all data recorded on the case report forms.

Datentyp

text

Date
Beschreibung

I have assumed reponsibility for completeness and accuracy of all data recorded on the case report forms.

Datentyp

date

Alias
UMLS CUI [1]
C0807937
Zum Seitenanfang zurückkehren

Ähnliche Modelle

end of study starting dose of ropinirole Parkinson's Disease 101468/166

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Administrative Data
C1320722 (UMLS CUI-1)
patient's initials
Item
Patient Initials
text
C2986440 (UMLS CUI [1])
patient number
Item
Patient No.
integer
C1830427 (UMLS CUI [1])
date of visit
Item
Date of Visit
date
C1320303 (UMLS CUI [1])
Item Group
COMPLETION OF TREATMENT PHASE
C0580352 (UMLS CUI-1)
date of study termination
Item
Date of termination
date
C0011008 (UMLS CUI [1,1])
C0008972 (UMLS CUI [1,2])
C0013135 (UMLS CUI [1,3])
Item
Did the patient remain on study drug through Day 7?
integer
patient's study participation status
Code List
Did the patient remain on study drug through Day 7?
CL Item
YES (1)
CL Item
NO, discontinued study drug prematurely (2)
Item
Did the patient remain on study drug through Day 7?
integer
patient's study participation status
Code List
Did the patient remain on study drug through Day 7?
CL Item
Adverse event, specify AE (Adverse event must be recorded on the Adverse Events CRF.) (1)
CL Item
Patientrequest (unrelated to AE), specify  (2)
CL Item
Non-compliance(unrelatedto an AE), specify (3)
CL Item
Investigatorjudgement, specify  (4)
CL Item
Termination of patient dosing by sponsor (5)
CL Item
Protocolviolation, specify  (6)
CL Item
Death, complete the Patient Death CRF (7)
CL Item
Other, specify (8)
Item Group
COMPLETION THROUGH DAY 14
C2348568 (UMLS CUI-1)
Item
Did the patient complete study visits/prodcedures through Day 14?
integer
patient's study participation status
Code List
Did the patient complete study visits/prodcedures through Day 14?
CL Item
YES (1)
CL Item
NO, check the one most significant reason below (2)
Item
Did the patient complete study visits/prodcedures through Day 14?
integer
patient's study participation status
Code List
Did the patient complete study visits/prodcedures through Day 14?
CL Item
Death, complete the Patient Death CRF  (1)
CL Item
Lost to follow-up  (2)
CL Item
Other, specify (3)
date of last contact
Item
Date of last contact
date
C0805839 (UMLS CUI [1])
Item Group
PATIENT DEATH
C1306577 (UMLS CUI-1)
date of death
Item
Date of death
date
C1148348 (UMLS CUI [1])
Item
Was an autopsy performed?
integer
C0004398 (UMLS CUI [1])
autopsy
Code List
Was an autopsy performed?
CL Item
YES (1)
CL Item
NO (2)
primary cause of death
Item
Primary cause of death
text
C0007465 (UMLS CUI [1])
underlying causes of death
Item
Underlying cause(s) of death
text
C0007465 (UMLS CUI [1])
Item
Was death related to study drug?
integer
C0011065 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
death related to study drug
Code List
Was death related to study drug?
CL Item
YES (1)
CL Item
NO (2)
Item Group
INVESTIGATOR'S SIGNATURE
C2346576 (UMLS CUI-1)
investigator's signature
Item
Signature
text
signature date
Item
Date
date
C0807937 (UMLS CUI [1])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video